leadf
logo-loader
viewEXMceuticals

EXMceuticals strikes THC distillate supply agreement for its upcoming Portuguese refinery

Econnabis SAS, a subsidiary of Plena Global Holdings Inc, will supply up to 200 kilograms of GMP-compliant THC distillate

EXMceuticals -
EXMceuticals is planning to leverage its existing Portuguese operations to position itself as a major European supplier of cannabinoid formulations

EXMceuticals Inc (CSE:EXM) announced Thursday it had struck a THC distillate supply deal for its proposed Portugal refinery.

The agreement sees Econnabis SAS, a subsidiary of Plena Global Holdings Inc, supplying up to 200 kilograms of GMP-compliant THC distillate to Vancouver-based EXMceuticals at a time when the European cannabis market is seeing increased demand for cannabis-related products.

EXMceuticals is planning to leverage its existing Portuguese operations to position itself as a major European supplier of cannabinoid formulations.

READ: EXMceuticals secures supply and offtake agreements-in-principle for proposed Portugal refinery

“The demand will explode in the next few years as the European cannabis industry continues to develop into one of the largest cannabis markets in the world and more countries require the use of EU GMP standards,” CEO Jonathan Summers told shareholders in a statement.

“Securing valuable sources of ingredients with consistent, large-scale suppliers such as Plena Global is more important than ever for the buildout of the EXM supply chain. Plena Global’s capacity and expertise in genetics will complement EXM activities in Portugal, providing customized ingredients to clients.”

British Columbia’s Plena Global supplies medical-grade cannabis products to licensed producers and pharmaceutical companies worldwide from its operations in Colombia. The company’s focus has been on commercializing cannabinoid formulations evolving with market demand, according to EXMCeuticals.

“CBD is truly becoming a revolutionary input for the cannabis and wellness market and research points to other interesting cannabinoids Plena Global can provides to us such as CBG and CBN,” Summers added. “The tremendous amount of work that Plena Global has completed to date gives us a great deal of confidence that our collaborative approach to deliver the right inputs to costumers will be unmatched.”

Market making contract

EXMceuticals also said it has retained Independent Trading Group Inc (ITG) to provide market-making services and Luminous Capital Ltd as financial advisor. ITG will receive $6,000 per month for a three-month term, renewable on a month-to-month basis following the initial three-month period, while Luminous will receive 1 million restricted shares of EXMceuticals.

“ITG and Luminous will provide value for shareholders given the milestones achieved and anticipated, we are now looking to engage with a far wider audience and engage with financials institution in financing our facility in Portugal,” Summers said. “I am confident that this new advisory relationship will help EXM move to a different level.”

EXMceuticals is currently creating an industrial-scale and pharmaceutical grade extraction and refining unit inside the European Union near Lisbon in Portugal. It also has an existing and licensed cannabis research and development facility and pilot refinery in Portugal.

Contact Angela at angela@proactiveinvestors.com

Follow her on Twitter @AHarmantas

Quick facts: EXMceuticals

Price: 0.17 CAD

CSE:EXM
Market: CSE
Market Cap: $6.72 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of EXMceuticals named herein, including the promotion by the Company of EXMceuticals in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

EXMceuticals now '100% focused on being a refining bioscience business in...

EXMceuticals Inc's (CSE:EXM) Jonathan Summers speaks to Proactive London's Katie Pilbeam about their cannabis research and development. Summers explains that the company has recently transitioned from being active in Africa to focusing their attentions solely onto Portugal. The company...

on 14/9/20

3 min read